Navigation Links
University of Miami biomedical engineer
Date:12/17/2008

CORAL GABLES, FL (December 17, 2008)-Baruch Barry Lieber, Ph.D., professor of biomedical engineering at the University of Miami College of Engineering and professor of radiology at the University of Miami Miller School of Medicine, has received a grant from the National Institute of Neurological Disorders and Stroke (NINDS), to support research studies that offer promise in the treatment of brain aneurysms.

The $1.9 million grant administered over a period of five years will help fund the development and optimization of assistive technology for a device created by Lieber to help heal brain aneurysms.

"Dr. Lieber's project addresses the important need for methods to treat brain aneurysms," said Eugene Golanov, M.D., Ph.D., program director of NINDS. "Although there are clinically available techniques to prevent aneurysm rupture, they are not ideal for all patients. We are optimistic that Dr. Lieber's work will lead to a useful alternative therapy."

The project for which Lieber won the award is titled, "Flow Divertors to Cure Cerebral Aneurysms." The focus of the research is to develop a tubular mesh-like device, which can be placed into cerebral arteries via catheters, to reduce the blood flow in an aneurysm, while keeping the arteries open to supply oxygen to the brain tissue.

"Slowing down the blood flow within the aneurysm leads to natural clotting, which prevents rupture of the aneurysm and elicits a healthy scar-response from the body, thus restoring the diseased arterial segment to its normal state," explained Lieber.

Dr. Lieber, is a professor of biomedical engineering in UM's College of Engineering, with a secondary appointment in the Department of Radiology at the Miller School of Medicine. He works in conjunction with the Vascular Biology Institute (VBI) on the medical campus. The VBI deals with all aspects of vascular function in health and disease with a focus on angiogenesis, coronary artery disease, aneurysm, and stroke, explained Keith Webster, Ph.D., director, professor and Walter G. Ross chair of the VBI.

"Dr. Lieber spearheads the aneurysm and stroke studies and has developed technology that is changing the field and will directly impact clinical treatments," said Webster. "We are working with Dr. Lieber's group within the VBI combining our novel gene and stem cell technologies with his cutting edge bioengineering approaches to develop new treatments that can be rapidly translated into clinical applications."

The collaboration between the College of Engineering and the Miller School of Medicine is part of an ongoing effort to forge interdisciplinary cooperation, said Ozcan Ozdamar, PhD., professor and chairman of the University of Miami Department of Biomedical Engineering.

"Dr. Lieber is an outstanding biomedical engineer and researcher with an established record," said Ozdamar. "His award is the result of our continuing collaboration between the College of Engineering and the Miller School of Medicine, aimed at finding innovative solutions to challenging medical problems"


'/>"/>

Contact: Marie Guma-Diaz
m.gumadiaz@umiami.edu
305-284-1601
University of Miami
Source:Eurekalert

Related biology news :

1. A study by the MUHC and McGill University opens a new door to understanding cancer
2. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
3. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
4. Bioengineers at University of Pennsylvania devise nanoscale system to measure cellular forces
5. Binghamton University researchers investigate evolving malaria resistance
6. Antioxidant to retard wrinkles discovered by Hebrew University researcher
7. Society for General Microbiology 161st Meeting, University of Edinburgh
8. Boston University biomedical engineers find chink in bacterias armor
9. KAUST and American University in Cairo to collaborate on research and academic development
10. UNH becomes first university in nation to use landfill gas as primary energy source
11. University of Minnesota study refutes belief that black men have more aggressive prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2016)... , June 20, 2016 Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... prisons involved, it has secured the final acceptance ... facilities for Managed Access Systems (MAS) installed. Furthermore, ... facilities to be installed by October, 2016. MAS ...
(Date:6/9/2016)... 2016 Paris Police Prefecture ... security solution to ensure the safety of people and operations ... the major tournament Teleste, an international technology group ... announced today that its video security solution will be utilised ... up public safety across the country. The system roll-out is ...
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016  Global demand for enzymes is ... 2020 to $7.2 billion.  This market includes enzymes ... products, biofuel production, animal feed, and other markets) ... biocatalysts). Food and beverages will remain the largest ... consumption of products containing enzymes in developing regions.  ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology: